Cargando…

Use of Complementary and Alternative Medicine in the context of cancer; prevalence, reasons for use, disclosure, information received, risks and benefits reported by people with cancer in Norway 

BACKGROUND: Research exploring the use of specific Complementary and Alternative Medicine (CAM) modalities by Norwegian cancer patients is sparse. The aims of this study were therefor to map the different CAM modalities cancer patients use and further investigate their rationale for use, communicati...

Descripción completa

Detalles Bibliográficos
Autores principales: Kristoffersen, Agnete E., Nilsen, Jorunn V., Stub, Trine, Nordberg, Johanna Hök, Wider, Barbara, Mora, Dana, Nakandi, Kiwumulo, Bjelland, Mona
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9336131/
https://www.ncbi.nlm.nih.gov/pubmed/35906578
http://dx.doi.org/10.1186/s12906-022-03606-0
_version_ 1784759478929850368
author Kristoffersen, Agnete E.
Nilsen, Jorunn V.
Stub, Trine
Nordberg, Johanna Hök
Wider, Barbara
Mora, Dana
Nakandi, Kiwumulo
Bjelland, Mona
author_facet Kristoffersen, Agnete E.
Nilsen, Jorunn V.
Stub, Trine
Nordberg, Johanna Hök
Wider, Barbara
Mora, Dana
Nakandi, Kiwumulo
Bjelland, Mona
author_sort Kristoffersen, Agnete E.
collection PubMed
description BACKGROUND: Research exploring the use of specific Complementary and Alternative Medicine (CAM) modalities by Norwegian cancer patients is sparse. The aims of this study were therefor to map the different CAM modalities cancer patients use and further investigate their rationale for use, communication about use, self-reported benefits and harms, and their sources of information about the different modalities. METHODS: In cooperation with the Norwegian Cancer Society (NCS), we conducted an online cross-sectional study among members of their user panel with present or previously cancer (n = 706). The study was carried out in September/October 2021 using a modified cancer-specific version of the International Questionnaire to Measure Use of Complementary and Alternative Medicine (I-CAM-Q). In total, 468 members, 315 women and 153 men, agreed to participate resulting in a response rate of 67.2%. The study was reported in accordance with the National Research Center in Complementary and Alternative Medicine’s (NAFKAM) model of reporting CAM use. RESULTS: A large proportion of the participants (79%, n = 346) had used some form of CAM with a mean of 3.8 modalities each (range 1-17); 33% (n = 143) had seen a CAM provider, 52% (n = 230) had used natural remedies, while 58% (n = 253) had used self-help practices. Most of the participants used CAM to increase their quality of life, cope with the cancer disease or for relaxation/well-being (64%-94%), mostly with high satisfaction and low rates of adverse effects. Few used CAM to treat cancer or prevent it from spreading (16%, n = 55). The main information sources were health care providers (47%), the internet (47%), and family and friends (39%). More than half (59%) of the cancer patients discussed their use of at least one CAM modality with a physician. CONCLUSIONS: The results of this survey will provide health professionals with more in-depth insight into the patterns of CAM use by cancer patients and facilitate better-informed discussions with their patients. Considering the high use of CAM, reliable information provision supporting cancer care providers’ knowledge and health literacy among patients as well as good communication are crucial. The cooperation between the NCS and NAFKAM provides an example of how to address these issues.
format Online
Article
Text
id pubmed-9336131
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-93361312022-07-29 Use of Complementary and Alternative Medicine in the context of cancer; prevalence, reasons for use, disclosure, information received, risks and benefits reported by people with cancer in Norway  Kristoffersen, Agnete E. Nilsen, Jorunn V. Stub, Trine Nordberg, Johanna Hök Wider, Barbara Mora, Dana Nakandi, Kiwumulo Bjelland, Mona BMC Complement Med Ther Research BACKGROUND: Research exploring the use of specific Complementary and Alternative Medicine (CAM) modalities by Norwegian cancer patients is sparse. The aims of this study were therefor to map the different CAM modalities cancer patients use and further investigate their rationale for use, communication about use, self-reported benefits and harms, and their sources of information about the different modalities. METHODS: In cooperation with the Norwegian Cancer Society (NCS), we conducted an online cross-sectional study among members of their user panel with present or previously cancer (n = 706). The study was carried out in September/October 2021 using a modified cancer-specific version of the International Questionnaire to Measure Use of Complementary and Alternative Medicine (I-CAM-Q). In total, 468 members, 315 women and 153 men, agreed to participate resulting in a response rate of 67.2%. The study was reported in accordance with the National Research Center in Complementary and Alternative Medicine’s (NAFKAM) model of reporting CAM use. RESULTS: A large proportion of the participants (79%, n = 346) had used some form of CAM with a mean of 3.8 modalities each (range 1-17); 33% (n = 143) had seen a CAM provider, 52% (n = 230) had used natural remedies, while 58% (n = 253) had used self-help practices. Most of the participants used CAM to increase their quality of life, cope with the cancer disease or for relaxation/well-being (64%-94%), mostly with high satisfaction and low rates of adverse effects. Few used CAM to treat cancer or prevent it from spreading (16%, n = 55). The main information sources were health care providers (47%), the internet (47%), and family and friends (39%). More than half (59%) of the cancer patients discussed their use of at least one CAM modality with a physician. CONCLUSIONS: The results of this survey will provide health professionals with more in-depth insight into the patterns of CAM use by cancer patients and facilitate better-informed discussions with their patients. Considering the high use of CAM, reliable information provision supporting cancer care providers’ knowledge and health literacy among patients as well as good communication are crucial. The cooperation between the NCS and NAFKAM provides an example of how to address these issues. BioMed Central 2022-07-29 /pmc/articles/PMC9336131/ /pubmed/35906578 http://dx.doi.org/10.1186/s12906-022-03606-0 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Kristoffersen, Agnete E.
Nilsen, Jorunn V.
Stub, Trine
Nordberg, Johanna Hök
Wider, Barbara
Mora, Dana
Nakandi, Kiwumulo
Bjelland, Mona
Use of Complementary and Alternative Medicine in the context of cancer; prevalence, reasons for use, disclosure, information received, risks and benefits reported by people with cancer in Norway 
title Use of Complementary and Alternative Medicine in the context of cancer; prevalence, reasons for use, disclosure, information received, risks and benefits reported by people with cancer in Norway 
title_full Use of Complementary and Alternative Medicine in the context of cancer; prevalence, reasons for use, disclosure, information received, risks and benefits reported by people with cancer in Norway 
title_fullStr Use of Complementary and Alternative Medicine in the context of cancer; prevalence, reasons for use, disclosure, information received, risks and benefits reported by people with cancer in Norway 
title_full_unstemmed Use of Complementary and Alternative Medicine in the context of cancer; prevalence, reasons for use, disclosure, information received, risks and benefits reported by people with cancer in Norway 
title_short Use of Complementary and Alternative Medicine in the context of cancer; prevalence, reasons for use, disclosure, information received, risks and benefits reported by people with cancer in Norway 
title_sort use of complementary and alternative medicine in the context of cancer; prevalence, reasons for use, disclosure, information received, risks and benefits reported by people with cancer in norway 
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9336131/
https://www.ncbi.nlm.nih.gov/pubmed/35906578
http://dx.doi.org/10.1186/s12906-022-03606-0
work_keys_str_mv AT kristoffersenagnetee useofcomplementaryandalternativemedicineinthecontextofcancerprevalencereasonsforusedisclosureinformationreceivedrisksandbenefitsreportedbypeoplewithcancerinnorway
AT nilsenjorunnv useofcomplementaryandalternativemedicineinthecontextofcancerprevalencereasonsforusedisclosureinformationreceivedrisksandbenefitsreportedbypeoplewithcancerinnorway
AT stubtrine useofcomplementaryandalternativemedicineinthecontextofcancerprevalencereasonsforusedisclosureinformationreceivedrisksandbenefitsreportedbypeoplewithcancerinnorway
AT nordbergjohannahok useofcomplementaryandalternativemedicineinthecontextofcancerprevalencereasonsforusedisclosureinformationreceivedrisksandbenefitsreportedbypeoplewithcancerinnorway
AT widerbarbara useofcomplementaryandalternativemedicineinthecontextofcancerprevalencereasonsforusedisclosureinformationreceivedrisksandbenefitsreportedbypeoplewithcancerinnorway
AT moradana useofcomplementaryandalternativemedicineinthecontextofcancerprevalencereasonsforusedisclosureinformationreceivedrisksandbenefitsreportedbypeoplewithcancerinnorway
AT nakandikiwumulo useofcomplementaryandalternativemedicineinthecontextofcancerprevalencereasonsforusedisclosureinformationreceivedrisksandbenefitsreportedbypeoplewithcancerinnorway
AT bjellandmona useofcomplementaryandalternativemedicineinthecontextofcancerprevalencereasonsforusedisclosureinformationreceivedrisksandbenefitsreportedbypeoplewithcancerinnorway